PortfoliosLab logoPortfoliosLab logo
ENVX vs. CRSP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ENVX vs. CRSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enovix Corp (ENVX) and CRISPR Therapeutics AG (CRSP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ENVX achieves a 12.59% return, which is significantly higher than CRSP's -0.69% return.


ENVX

1D
-4.52%
1M
21.93%
YTD
12.59%
6M
-1.32%
1Y
18.61%
3Y*
-12.97%
5Y*
10Y*

CRSP

1D
0.12%
1M
-2.80%
YTD
-0.69%
6M
-6.98%
1Y
36.91%
3Y*
-7.12%
5Y*
-14.40%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ENVX vs. CRSP - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ENVX
Enovix Corp
12.59%-23.14%-13.18%0.64%-54.40%53.86%
CRSP
CRISPR Therapeutics AG
-0.69%33.23%-37.12%54.00%-46.36%-40.38%

Correlation

The correlation between ENVX and CRSP is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.34

Correlation (3Y)
Calculated over the trailing 3-year period

0.43

Correlation (All Time)
Calculated using the full available price history since Jul 16, 2021

0.45

The correlation between ENVX and CRSP shifts across timeframes, from 0.34 (1 year) to 0.45 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ENVX:

$1.79B

CRSP:

$5.00B

EPS

ENVX:

-$183.56

CRSP:

-$6.24

PS Ratio

ENVX:

0.23

CRSP:

1.16K

PB Ratio

ENVX:

0.01

CRSP:

2.76

Total Revenue (TTM)

ENVX:

$7.63B

CRSP:

$4.10M

Gross Profit (TTM)

ENVX:

$1.56B

CRSP:

-$171.17M

EBITDA (TTM)

ENVX:

-$43.98B

CRSP:

-$509.21M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ENVX vs. CRSP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ENVX
ENVX Risk / Return Rank: 4848
Overall Rank
ENVX Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
ENVX Sortino Ratio Rank: 5353
Sortino Ratio Rank
ENVX Omega Ratio Rank: 5151
Omega Ratio Rank
ENVX Calmar Ratio Rank: 4646
Calmar Ratio Rank
ENVX Martin Ratio Rank: 4444
Martin Ratio Rank

CRSP
CRSP Risk / Return Rank: 5858
Overall Rank
CRSP Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
CRSP Sortino Ratio Rank: 6060
Sortino Ratio Rank
CRSP Omega Ratio Rank: 5656
Omega Ratio Rank
CRSP Calmar Ratio Rank: 5959
Calmar Ratio Rank
CRSP Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ENVX vs. CRSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enovix Corp (ENVX) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ENVXCRSPDifference

Sharpe ratio

Return per unit of total volatility

0.21

0.60

-0.39

Sortino ratio

Return per unit of downside risk

0.95

1.28

-0.33

Omega ratio

Gain probability vs. loss probability

1.12

1.15

-0.03

Calmar ratio

Return relative to maximum drawdown

0.27

0.88

-0.61

Martin ratio

Return relative to average drawdown

0.40

1.49

-1.09

ENVX vs. CRSP - Sharpe Ratio Comparison

The current ENVX Sharpe Ratio is 0.21, which is lower than the CRSP Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of ENVX and CRSP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ENVXCRSPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.21

0.60

-0.39

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.24

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.13

0.23

-0.36

Drawdowns

ENVX vs. CRSP - Drawdown Comparison

The maximum ENVX drawdown since its inception was -84.76%, roughly equal to the maximum CRSP drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for ENVX and CRSP.


Loading charts...

Drawdown Indicators


ENVXCRSPDifference

Max Drawdown

Largest peak-to-trough decline

-84.76%

-85.11%

+0.35%

Max Drawdown (1Y)

Largest decline over 1 year

-69.62%

-42.25%

-27.37%

Max Drawdown (3Y)

Largest decline over 3 years

-75.42%

-64.91%

-10.51%

Max Drawdown (5Y)

Largest decline over 5 years

-80.68%

Current Drawdown

Current decline from peak

-73.74%

-75.20%

+1.46%

Average Drawdown

Average peak-to-trough decline

-62.52%

-49.17%

-13.35%

Ulcer Index

Depth and duration of drawdowns from previous peaks

46.68%

24.92%

+21.76%

Volatility

ENVX vs. CRSP - Volatility Comparison

Enovix Corp (ENVX) has a higher volatility of 29.00% compared to CRISPR Therapeutics AG (CRSP) at 14.90%. This indicates that ENVX's price experiences larger fluctuations and is considered to be riskier than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ENVXCRSPDifference

Volatility (1M)

Calculated over the trailing 1-month period

29.00%

14.90%

+14.10%

Volatility (6M)

Calculated over the trailing 6-month period

57.38%

42.49%

+14.89%

Volatility (1Y)

Calculated over the trailing 1-year period

87.19%

61.68%

+25.51%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

93.48%

60.46%

+33.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

93.48%

64.27%

+29.21%

Dividends

ENVX vs. CRSP - Dividend Comparison

Neither ENVX nor CRSP has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ENVX vs. CRSP - Financials Comparison

This section allows you to compare key financial metrics between Enovix Corp and CRISPR Therapeutics AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20222023202420252026
7.60B
1.46M
(ENVX) Total Revenue
(CRSP) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ENVX and CRSP have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ENVX has higher volatility (29.00%) compared to CRSP (14.90%). In terms of maximum drawdown, ENVX dropped -84.76% vs CRSP's -85.11%.

CRSP currently has the higher Sharpe Ratio (0.60 vs 0.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ENVX and CRSP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer